Cypherpunk Technologies Inc.
CYPH - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$303.89M
Close$
$0.20
93.9% downside
Current Fair Value
93.9% downsideOvervalued by 93.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $303.89 Million |
|---|---|
| Enterprise Value | $296.41 Million |
| Earnings per Share | $0.07 |
| Beta | 0.06 |
| Outstanding Shares | 176,260,808 |
Return
| Return on Equity | 26.49% |
|---|---|
| Return on Assets | 25.81% |
| Return on Invested Capital | -28.72% |
Valuation & Multiples
| P/E Ratio | 4.78 |
|---|---|
| PEG | -0.85 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1418.21 |
| Enterprise Value to EBIT | -7.31 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.03
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$0.03
Consensus analyst estimateRevenue Estimate
$13.20 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Leap Therapeutics Inc
6 employees
CEO: Douglas E. Onsi
Cypherpunk Technologies Inc. is a privacy-focused technology company that combines a digital asset treasury strategy centered on Zcash (ZEC) with the development of novel cancer therapies through its subsidiary. The company's mission is ...